Alpha 2.0
Login Register
» Authors » Thomas R Ziegler

Thomas R Ziegler

Explore the profile of Thomas R Ziegler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 241
Citations 5199
Followers 0
Related Specialties
Nutritional Sciences
Endocrinology
General Medicine
Top 10 Co-Authors
Dean P Jones
Vin Tangpricha
Jessica A Alvarez
Li Hao
Henry M Blumberg
Greg S Martin
Li H Gu
Menghua Luo
Youngja Park
Daniel P Griffith
Published In
JPEN J Parenter Enteral Nutr
Am J Clin Nutr
Nutrition
Clin Nutr
J Nutr
Affiliations
Soon will be listed here.
Recent Articles
1.
High-Intensity Interval Training for Individuals With Isolated Impaired Fasting Glucose: Protocol for a Proof-of-Concept Randomized Controlled Trial
Thirunavukkarasu S, Ziegler T, Weber M, Staimez L, Lobelo F, Millard-Stafford M, et al.
JMIR Res Protoc . 2025 Feb; 14:e59842. PMID: 39977858
Background: Standard lifestyle interventions have shown limited efficacy in preventing type 2 diabetes among individuals with isolated impaired fasting glucose (i-IFG). Hence, tailored intervention approaches are necessary for this high-risk...
2.
Non-invasive markers of hepatic steatosis and fibrosis following INSTI initiation in women with HIV
Yu M, Gerig L, Mehta C, Musonge-Effoe J, Alvarez J, Ofotokun I, et al.
Clin Infect Dis . 2025 Feb; PMID: 39899358
Background: The impact of integrase strand-transfer inhibitors (INSTIs) on steatotic liver disease in women with HIV (WWH) is unknown. Methods: Using data collected in the Women's Interagency HIV Study from...
3.
Low-added sugar dietary intervention study to mitigate glucose intolerance and improve body composition in adults with cystic fibrosis: a protocol of a double-blind, randomised study
Zaveri S, Stecenko A, Hunt W, Goss A, Sharma P, Hartman T, et al.
BMJ Open . 2024 Dec; 14(12):e092503. PMID: 39725418
Introduction: People with cystic fibrosis (PwCF) are at high risk for developing cystic fibrosis (CF)-related diabetes (CFRD), which worsens morbidity and mortality. Although the pathological events leading to the development...
4.
"Short and Long-term Body Weight Change Following the Switch to or the Addition of Integrase Inhibitors in Persons with HIV Differs by Sex"
Lahiri C, Mehta C, Yang Q, Maramba T, Musonge-Effoe J, Yang C, et al.
Clin Infect Dis . 2024 Sep; PMID: 39324701
Background: Sex-specific, long-term, body weight change in persons with HIV (PWH) following switch to regimens containing integrase strand-transfer inhibitors (INSTIs) is unknown. Methods: We compared PWH enrolled in the MACS/WIHS...
5.
Impact of high-dose cholecalciferol (vitamin D3) and inulin prebiotic on intestinal and airway microbiota in adults with cystic fibrosis: A 2 × 2 randomized, placebo-controlled, double-blind pilot study
Suppakitjanusant P, Wang Y, Sivapiromrat A, Hu C, Binongo J, Hunt W, et al.
J Clin Transl Endocrinol . 2024 Aug; 37:100362. PMID: 39188269
Background: Cystic fibrosis (CF) is a multi-organ disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). Individuals with CF often have gastrointestinal (GI) dysbiosis due to chronic...
6.
High-resolution plasma metabolomics and thiamine status in critically Ill adult patients
Gundogan K, Nellis M, Ozer N, Ergul S, Sahin G, Temel S, et al.
Metabolomics . 2024 Jul; 20(4):83. PMID: 39066851
Introduction: Thiamine (Vitamin B1) is an essential micronutrient and is classically considered a co-factor in energy metabolism. The association between thiamine status and whole-body metabolism in critical illness has not...
7.
Linoleic acid blunts early osteoblast differentiation and impairs oxidative phosphorylation in vitro
Nesbeth P, Ziegler T, Tripathi A, Dabeer S, Weiss D, Hao L, et al.
Prostaglandins Leukot Essent Fatty Acids . 2024 May; 201:102617. PMID: 38788347
Background: Linoleic acid (LNA), an essential polyunsaturated fatty acid (PUFA), plays a crucial role in cellular functions. However, excessive intake of LNA, characteristic of Western diets, can have detrimental effects...
8.
Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D) (Pre-D trial) in adults with...
Sivapiromrat A, Suppakitjanusant P, Wang Y, Hu C, Binongo J, Hunt W, et al.
Contemp Clin Trials Commun . 2024 Mar; 38:101278. PMID: 38435430
Individuals with cystic fibrosis (CF) have dysfunctional intestinal microbiota and increased gastrointestinal (GI) inflammation also known as GI dysbiosis. It is hypothesized that administration of high-dose cholecalciferol (vitamin D) together...
9.
Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 × 2 trial of administration of prebiotics and cholecalciferol (vitamin D) (Pre-D Trial) in adults with...
Sivapiromrat A, Suppakitjanusant P, Wang Y, Binongo J, Hunt W, Gewirtz A, et al.
medRxiv . 2024 Feb; PMID: 38343811
Individuals with cystic fibrosis (CF) have dysfunctional intestinal microbiota and increased gastrointestinal (GI) inflammation also known as GI dysbiosis. It is hypothesized that administration of high-dose cholecalciferol (vitamin D) together...
10.
Vitamin D for glycemic control following an acute pulmonary exacerbation: A secondary analysis of a multicenter, double-blind, randomized, placebo-controlled trial in adults with cystic fibrosis
Sivapiromrat A, Hunt W, Alvarez J, Ziegler T, Tangpricha V
medRxiv . 2024 Feb; PMID: 38343807
Individuals with cystic fibrosis (CF) often incur damage to pancreatic tissue due to a dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) protein, leading to altered chloride transport on epithelial surfaces...